Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Charles River Laboratories International, Inc. and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine), a leading medical education institution with a world-renowned medical research field of stem cell biology and ...
read more
Wednesday, March 20, 2024
Paradigm Clinical Research, a clinical research site business, announced the opening of its flagship clinic in San Diego, California, coinciding with the celebration of the company’s 15th anniversary.
read more
Specialist Biometrics CRO, Veramed, announced the appointment of Karen Curran as Chief Strategy Officer at Veramed. Karen joins during a period of substantial global growth for the company.
read more
SCHOTT Pharma plans to make Wilson, North Carolina home to its newest site. The investment is supported by $21 million in state and local incentive awards and will expand SCHOTT Group’s presence in the United States, a strategic market in its growth ...
read more
Kindeva Drug Delivery has named Jennifer Riter as Vice President of Analytical Services to head up the recently announced analytical services global business unit.
read more
Cambrex announced that it is nearing the completion of a 5-year, $100-million-dollar investment strategy, one year ahead of schedule.
read more
Johnson & Johnson announced that the FDA Oncologic Drugs Advisory Committee (ODAC) recommends CARVYKTI® (ciltacabtagene autoleucel, cilta-cel) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least...
read more
W. R. Grace & Co. (Grace) announced the opening of its expanded fine chemical contract development and manufacturing (CDM) facility in South Haven, MI. Grace executives and local community leaders joined more than 200 employees at the site for a ...
read more
Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, received CDMO Leadership Awards in all six categories - Capabilities, Compatibility, Expertise, Quality, Reliability, and Service for both...
read more
DifGen Pharmaceuticals LLC announced that it has signed and closed an all-cash transaction through its subsidiary Aveva Drug Delivery Systems Inc. to purchase the operating and manufacturing assets of an FDA-registered manufacturing facility located ...
read more
Cellipont Bioservices, a cell therapy Contract Development and Manufacturing Organization (CDMO), and Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies to treat a broad range of hematological and ...
read more
Syngene International, a global contract research, development and manufacturing organization (CRDMO), announced that its newly upgraded biologics facility - Unit 3 - would be operational for clinical and commercial supply in the second half of 2024.
read more
Noramco announced its launch of the Noramco Group, a newly created comprehensive North American-based supply chain solution including subsidiaries Purisys, Noramco, and the newly acquired drug product CDMO, Halo Pharma.
read more
Aptar Pharma, part of AptarGroup, Inc., announced the next phase of its global capacity expansion plan in North America, at its Aptar Congers, New York site.
read more
Charles River Laboratories International, Inc. announced an AAV9 production program agreement. As part of Charles River’s Cell and Gene Therapy (CGT) Accelerator Program (CAP), Navega will have access to established contract development and ...
read more